Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21892015 | 0.86 | CYP3A4 (0.57) | CYP3A4SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL18214384 | 0.75 | CYP3A4 (0.72) | CYP3A4SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL20150695 | 0.74 | CYP3A4 (0.43) | CYP3A4KMT2A | |
| SCHEMBL20150779 | 0.67 | CYP3A4 (0.47) | CYP3A4SLC6A2SLC6A4SLC6A3DRD1 | |
| SCHEMBL5670508 | 0.64 | CYP3A4 (0.76) | CYP3A4SLC6A2SLC6A4SLC6A3MAPT | |
| SCHEMBL5670506 | 0.64 | CYP3A4 (0.76) | CYP3A4SLC6A2SLC6A4SLC6A3MAPT | |
| Dihydrokawain SCHEMBL18214381 | 0.63 | CYP3A4 (1.00) | CYP3A4SLC6A2SLC6A4SLC6A3MAPT | |
| Dihydrokawain SCHEMBL2743647 | 0.63 | CYP3A4 (1.00) | CYP3A4SLC6A2SLC6A4SLC6A3MAPT | |
| Dihydrokawain SCHEMBL5672433 | 0.63 | CYP3A4 (1.00) | CYP3A4SLC6A2SLC6A4SLC6A3MAPT | |
| SCHEMBL24137898 | 0.62 | MEN1 (0.62) | CYP3A4SLC6A2SLC6A4SLC6A3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180134679-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | KUALITY HERBCEUTICS LLC (US) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134679-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | NQO1, VHL, XIAP | CYP3A4 2215/4885SLC6A2 2042/4885SLC6A4 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.